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Tissue-engineered skin equivalents based on primary isolated ﬁbroblasts and keratinocytes have been
shown to be useful tools for functional in vitro tests, including toxicological screenings and drug
development. In this study, a commercially available squamous cell carcinoma (SCC) cell line SCC-25 was
introduced into epidermal and full-thickness skin equivalents to generate human-based disease-in-a-dish
model systems. Interestingly, when cultured either in the epidermis or dermis of full-thickness skin
equivalents, SCC-25 cells formed hyper-keratinized tumor cell nests, a phenomenon that is frequently
seen in the skin of patients afﬂicted with SCC. Raman spectroscopy was employed for the label-free cell
phenotype characterization within the engineered skin equivalents and revealed the presence of dif-
ferential protein patterns in keratinocytes and SCC-25 cells. To conclude, the here presented SSC disease-
in-a-dish approaches offer the unique opportunity to model SSC in human skin in vitro, which will allow
further insight into SSC disease progression, and the development of therapeutic strategies.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license.1. Introduction
Among basal cell carcinoma, squamous cell carcinoma (SCC) is
the most common type of skin cancer. Every year, an estimated
400,000e600,000 new cases of cutaneous SCC are diagnosed
worldwide, predominantly occurring in sun-exposed skin areas of
elderly patients [1]. Although SCC is curable in most cases, treat-
ment at early disease stages is advisable since SCC has the potential
to spread and form metastases [1,2]. The development and expan-
sion of SCC is considered to be an accumulative process of cellular
malignant alterations within the epidermal skin layer [3]. SCC can
arise from so-called precancerous lesions, the most frequent beingepartment of Cell and Tissue
y. Tel.: þ49 711 970 4082;
fer.de (K. Schenke-Layland).
Ltd. Open access under CC BY-NC-SA licenactinic keratosis,which is induced byUV-radiation. Although actinic
keratosis may stay inconspicuous for several years, it is estimated
that 8e20% of untreated actinic keratosis turn into SCC [1]. Histo-
pathologically, actinic keratosis is associated with atypical kerati-
nocytes that are present within a thickened epidermal layer due to
abnormal keratin expression [1]. An advanced, pre-invasive stage of
cutaneous SCC is known as Bowen’s disease, which occurs as an
asymptotic, but well-deﬁned scaly plaque that affects all layers of
the epidermis [1]. Morphologically, the spatial organization of the
epidermis is destructed in Bowen’s disease; parakeratosis and
sometimes hyperkeratosis can be observed [1]. Pathological kera-
tinocytes proliferate, laterally expand and can appear as multinu-
cleated, dyskeratotic cells [1]. An invasive, aggressive SCC is
characterized by cancerous keratinocytes passing the basal lamina
and inﬁltrating the dermis, in which case a high risk for reoccur-
rence and the formation of metastases was reported [3].
Various risk factors have been identiﬁed to be involved in tumor
formation and progression, including exposure to UV-radiation,
immunosuppression, individual skin type or previous therapies
[4,5]. Less is known about the alterations that occur in the skin due
to risk factor exposure, which can ﬁnally lead to a malignant high-
risk SCC. In vitro toxicological screening on malignant cancer cellsse.
E. Brauchle et al. / Biomaterials 34 (2013) 7401e74077402have shown that a three-dimensional (3D) environment impacts
the response of malignant cells signiﬁcantly [6]. Furthermore,
previous work from our group has demonstrated the critical
importance of 3D environments for in vitromodels of the intestine,
trachea, and myocardium [7e9]. The establishment of a three-
dimensional in vitro test system for SCC would be of great beneﬁt
for the evaluation of therapies and a general better understanding
of the underlying mechanisms of the disease. In vitro skin equiva-
lents have been shown to be suitable tools to mimic functional and
structural key characteristics of human native skin [10]. Accord-
ingly, various tissue-engineered products are already commercially
available for topical substance testing or toxicity screening [10].
This skin-in-a-dish approach has the potential to be modiﬁed to
meet different application requirements. In vitro SCC skin models
were previously generated by the incorporation of different SCC cell
lines into the epidermis. However, these SCC in vitro models could
only be weakly discriminated from standard skin equivalents using
morphological and tumor marker expression analyses [11,12]. Here,
we generated a simpliﬁed epidermal skin equivalent that omits the
dermis as well as a full-thickness skin equivalent in order to mimic
the different aspects of SCC in vivo. An SCC cell line (SCC-25),
derived from tongue tissue of a 70-year-old patient afﬂicted with
SCC [13], was introduced in either epidermal or full-thickness skin
equivalents (Fig. 1). Although the epidermal disease-in-a-dish
models enabled the study of 3D culture effects on SCC-25 cells, they
did not allow for the monitoring of the impact of ﬁbroblast
signaling, which is crucial for the development of an invasive SCC
state in vivo. In previous studies, spontaneous invasion of SCC cell
lines could not be accomplished within an in vitro skin equivalent
[11,12]. Here, SCC cells were directly diffused within the dermal
collagen gel to establish an SSC model system that also mimics the
invasive SCC morphology. The co-culture of both healthy human
skin cells and malignant cells is important for the reproduction of
in vivo cellecell interactions and the in vivomicroenvironment that
inﬂuences and directs cell behavior [14]. Since cellular markers
were not sufﬁcient to discriminate SCC in vitro models from stan-
dard skin equivalents [11], we employed Raman spectroscopy on
full-thickness standard skin-in-a-dish and late-stage disease-in-a-
dishmodels. Raman spectroscopy is an emerging technology in the
ﬁeld of biomedical research that possesses great potential for the
non-invasive discrimination between healthy and pathological
cells in vitro [15]. In skin cancer diagnosis, Raman spectroscopy was
explored in vivo showing its suitability to differentiate betweenFig. 1. Schematic of (A) epidermal and (B) full-thickness skin equivalents depicting the stancancerous skin tissue and healthy skin regions [16]. Raman spec-
troscopy generates ﬁngerprints of the molecular constitution of a
biological sample; monochromatic laser light is thereby used to
excite vibration modes in molecules. Dependent on the excitation
mode, the photons from the incident beam can experience a
frequency-shift when scattered [17]. The frequency-shifted scat-
tered light is detected as a spectrum, where the resulting peaks are
speciﬁc for molecular bonds and their secondary structure. More-
over, Raman spectroscopy permits non-destructive measurements
on living cells and native tissues without the need for staining or
processing steps prior to the measurements [15]. In cancer
research, achievements using Raman spectroscopy as a diagnostic
tool were presented in various in vitro and in vivo studies [18,19]. In
a previous study, Raman spectroscopy enabled an accuracy of more
than 90% for the differentiation between non-tumorigenic and
tumorigenic skin cell lines [20]. Krishna et al. investigated Raman
spectroscopy on biopsy sections of oral squamous carcinoma and
non-malignant tissues. Here, spectral differences revealed
increased protein and DNA signals in the epidermal cell layer of
malignant tissue [21]. Our previous studies indicated that Raman
spectroscopy is a promising technology to analyze skin cells within
their 3D microenvironment [22], as well as key extracellular matrix
proteins such as collagen and elastin [15].2. Materials and methods
2.1. Human tissue samples
All research was carried out in compliance with the rules for investigation of
human subjects as deﬁned in the Declaration of Helsinki. Written informed consent
of the patients or parents of the patients was obtained according to the approval of
the Landesärztekammer Baden-Württemberg (F-2012-078; for normal foreskin
from elective surgeries) or the clinical ethics committee of the University Hospital
Tübingen (2012B02; for squamous cell carcinoma biopsies).2.2. Cell isolation and culture
Primary human ﬁbroblasts and keratinocytes were isolated from foreskin
samples (age: 2 monthse9 years). The isolation of primary cells was performed as
previously described [22]. SCC-25 cells were purchased from LGC Standards (Wesel,
Germany (¼ATCC; CRL1628)). SCC-25 cells were cultured in DMEM/F-12 medium
(Invitrogen, Karslruhe, Germany), supplemented with 1 mM sodium pyruvate (Life
Technologies GmbH, Darmstadt, Germany), 1.1 mM hydrocortisone (Sigma Aldrich,
Steinheim, Germany), 10% fetal calf serum (Life Technologies) and 1% gentamycin
(Invitrogen). Media exchange was performed every 2e3 days and cells were
passaged after reaching 70e80% conﬂuence.dard skin-in-a-dish model and the modiﬁed disease-in-a-dish models with SCC-25 cells.
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Skin equivalents were generated from primary isolated keratinocytes and SCC-
25 cells. A total amount of 3.15  105 cells was seeded on culture inserts (Millicell,
0.4 mm pores, Merck Chemicals GmbH, Schwalbach, Germany) in a standard 24-well
plate either as a) SCC-25 cells, b) keratinocytes or c) in a co-culture of both cell types
at a ratio of 100:1, 50:1, 10:1 and 1:1. Due to increasing the percentage of SCC-25
cells (100:1 to 1:1), early- and late-stage SCC disease-in-a-dish model systems
were generated (Fig. 1). For all cultures, we used EpiLife medium (Life Technologies),
supplemented with 1.5 mM CaCl2 (Merck, Darmstadt, Germany) and 1% gentamycin.
After two days of culture, the seeded inserts were transferred into a 6-well plate,
where they were lifted to the air-liquid interface and cultured in EpiLife medium
containing 250 mM ascorbic acid (Sigma Aldrich) to allow stratiﬁcation of the up-
permost cell layer. Medium was exchanged every 2e3 days. Epidermal skin equiv-
alents were processed for histological staining after a 14-day period of airlift-culture.
2.4. Full-thickness skin equivalents
Full-thickness skin-in-a-dish models, consisting of epidermis and dermis, were
generated and cultured according to a previously described modiﬁed protocol [22].
In this study, 1105 cells, either keratinocytes or SCC-25 cells, were seeded onto the
collagen type-I gel (Fraunhofer IGB, Stuttgart, Germany). Late-stage SCC disease-in-
a-dishmodel systems were created by seeding primary dermal ﬁbroblasts and SCC-
25 cells at a ratio of 10:1 into the dermal collagen gel (Fig. 1). A total amount of
0.4  105 cells was loaded into 400 ml of collagen gel.
2.5. Histological and immunohistochemical staining
Hematoxylin and eosin (HE) as well as immunohistochemical staining were
performed on epidermal and full-thickness skin equivalents, as well as on native
human SCC biopsies (male, 72 and 81 years). Immunohistochemical staining was
employed as previously described using the Dako EnVision kit (Dako, Hamburg,
Germany) [23], employing the primary antibodies: Ki67 (1:60, #M7240, Dako),
cytokeratin 5/6 (1:100, #M7237, Dako), cytokeratin 14 (1:100, #sc-53253, Santa
Cruz, Heidelberg, Germany) and E-cadherin (1:500, BD Biosciences, Heidelberg,
Germany). Bright-ﬁeld microscopy was performed with a Zeiss Axiovert 200 mi-
croscope using either a 20 or a 40 objective.
2.6. Set up of the Raman spectrometer
A custom-built Raman spectrometer was used for all measurements [24]. The
laser beam was set on 85 mW power and was guided through a 60 water im-
mersion objective (NA 1.2; Olympus, Hamburg, Germany). For the spectral detection,
a spectrograph (Kaiser Optical Systems Inc., Ann Arbor, MI, USA) as well as a near-
infrared-optimized and cooled CCD camera (Andor iDus, Belfast, Northern Ireland)
were integrated at the output port of the system. Raman spectra were acquired in
the wavenumber range of 0e2000 cm1.
2.7. Data acquisition and processing of Raman spectra
Raman spectra were recorded using the Andor Solis software package (Andor
iDus). Measurements were performed on single primary keratinocytes and SCC-25
cells in suspension after passaging as well as on the epidermis of full-thickness
standard skin-in-a-dish and late-stage disease-in-a-dish models. The acquisition
time per spectrumwas 100 s. In order to generate a representative set of spectra, 30
Raman spectra were taken per sample. All measurements were performed from
specimens on glass surfaces. After every ﬁve to ten measurements, a background
signal was taken from the glass. The background signal was subtracted from the
sample signal using the OPUS software 4.2 (Bruker Optik GmbH, Ettlingen, Ger-
many). Additionally, OPUS software 4.2 was used to cut the Raman spectra into the
spectral range of 400e1800 cm1 and to perform the baseline correction.Fig. 2. HE-stained sections of epidermal skin equivalents: (A) Standard epidermal skin-in-a-
cells, co-cultured at a ratio of 10:1, and (C) epidermal late-stage disease-in-a-dish model. Sc2.8. Principal Component Analysis (PCA)
PCA is a multivariate method utilized to analyze the variances in a spectral
dataset. PCA is valuable to identify signiﬁcant shifts in the spectra between two
sample groups [25]. Prior to the PCA computation, all Raman spectra were imported
to the UnscramblerX 10.2 Software (CAMO, Oslo, Norway). PCA was performed on
vector-normalized Raman spectra of primary keratinocytes and SCC-25 cells as well
as the respective in vitro skin models. In total, seven principal components (PCs)
were calculated using the NIPALS algorithm [26]. As a result of the PCA, every
spectrum is described by seven score values. Different score values for one
component indicate spectral shifts between sample groups.
3. Results
3.1. Integration of SCC-25 cells into epidermal skin equivalents
Epidermal skin equivalents were generated from keratinocytes,
co-cultured keratinocytes and SCC-25 cells at varying ratios, as well
as SCC-25 cells alone (Figs. 1 and 2; Suppl. Fig. 1). In standard
epidermal skin-in-a-dish models, cell stratiﬁcation and differenti-
ationwas observed, due to the exposure of keratinocytes to the air-
liquid interface (Fig. 2A). Early-stage disease-in-a-dish models,
where keratinocytes and SCC-25 cells were seeded at a ratio of 10:1,
formed a similar stratiﬁed epidermal layer (Fig. 2B). In these early-
stage disease-in-a-dishmodels, a cancerous epidermal morphology
was not observed. In contrast, late-stage disease-in-a-dish models
containing only SCC-25 cells showed less stratiﬁcation, with cells
retaining their nucleus (Fig. 2C). Interestingly, none of the
epidermal early-stage disease-in-a-dish models displayed promi-
nent tumor characteristics such as tumor cell aggregation or the
formation of keratin pearls. When varying the ratio of keratinocytes
and SCC-25 cells, we found that increasing numbers of SCC-25 cells
disturbed the formation of a regular structured epidermis
(Suppl. Fig. 1). A lack of spatial organization was previously
described for SCC in vivo [27]. Based on these results, we used SCC-
25 cells in the epidermis alone in order to establish a late-stage full-
thickness disease-in-a-dish model.
3.2. Integration of SCC-25 cells into full-thickness skin equivalents
Keratinocytes beneﬁt from soluble factors released by ﬁbro-
blasts when both cell types are co-cultured in standard full-
thickness skin equivalents [28,29]. To mimic the in vivo tumor
microenvironment, SCC-25 cells were integrated into full-thickness
skin equivalents, consisting of epidermal and dermal layers. In early
in vivo stages of the disease, SCC cells do not inﬁltrate the dermis,
but expand within the epidermal skin layer [1]. In order to generate
a disease-in-a-dishmodel system for this pre-invasive stage, SCC-25
cells were directly seeded onto the ﬁbroblast-containing dermis
(Fig. 3A and B). It has been reported that SCC cells in vivo produce
and accumulate keratins that lead to the formation of encapsulated
keratin pearls in the epidermis (Fig. 3C) [1]. Similar to the in vivo
milieu, we identiﬁed the presence of keratin accumulations (Fig. 3Adish, (B) epidermal early-stage disease-in-a-dish model with keratinocytes and SCC-25
ale bar equals 50 mm.
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formed multiple cell layers, but lacked spatial organization and a
stratiﬁed corneous layer. Additionally, this epidermal layer dis-
played small gaps, which are due to a lack of tight cellecell contact
formation, indicated by discontinuous staining of E-cadherin
(Fig. 3D). During the progression of the disease in vivo, SCC cells
migrate into the dermis and form typical tumor cell nests that
contain keratin accumulations (Fig. 3E). However, we did not
observe spontaneous invasion of the SCC-25 cells into the dermal
layer. In order to mimic this invasive disease stage in vitro, SCC-25
cells were seeded and co-cultured with ﬁbroblasts in the dermal
layer of full-thickness skin equivalents (Fig. 3F). In this late-stage
disease-in-a-dish model, we identiﬁed the formation of round cell
nests due to a high proliferative capacity of the SCC-25 cells, as
demonstrated by Ki67 staining (Fig. 4A). Additionally, the tumor
cell nests were positively stained for cytokeratin 5/6 (Fig. 4B)Fig. 3. HE-(AeC, E, F) and immunohistochemically (D) stained sections of in vivo squamous
disease-in-a-dish model with SCC-25 cells cultured in the epidermis. Arrows indicate kerat
patient. The arrow points to a keratin pearl in the epidermis. (D) E-cadherin staining (brow
(blue). (E) Late-stage SCC from an 81-year-old male patient. Arrows highlight tumor cell nes
dish model composed of ﬁbroblasts and SCC-25 cells that were seeded in a ratio of 10:1. Scand cytokeratin 14 (Fig. 4C), resembling keratin accumulations
observed in vivo [1].
3.3. Discrimination of full-thickness skin-in-a-dish and disease-in-
a-dish models by Raman spectroscopy
Raman spectroscopy has previously been demonstrated to be a
suitable technology for the label-free detection of molecular dif-
ferences between tumorigenic and healthy primary cells in vitro
[22,23]. Due to the lack of appropriate cellular marker proteins,
Raman spectroscopy was explored to analyze the epidermal
morphology of full-thickness skin-in-a-dish and late-stage disease-
in-a-dish models. The mean Raman spectra of skin-in-a-dish and
disease-in-a-dish models exhibited typical patterns of cellular
molecules, including signals from phenylalanine at 1003 cm1, CeH
vibrations at 1440 cm1 and amide I at 1660 cm1 [30]. Thecell carcinoma (SCC) and full-thickness skin equivalents. (A) Full-thickness late-stage
in accumulations. (B) Magniﬁcation of (A). (C) Section of SCC from a 72-year-old male
n) shows disrupted cellecell contacts. Hematoxylin was used as nuclear counterstain
ts and keratin accumulations in the dermis. (F) Section of the dermis of a disease-in-a-
ale bars equal 100 mm.
Fig. 4. Immunohistochemical staining of full-thickness late-stage disease-in-a-dish models. (A) Ki67 staining indicates the presence of highly proliferative SCC-25 cells within the
tumour nests, where also (B) cytokeratin 5/6 and (C) cytokeratin 14 are expressed (all in brown). Hematoxylin served as nuclear counterstain (blue). Scale bar equals 100 mm.
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ease-in-a-dish models, was comparable. Notably, the spectra of
disease-in-a-dish models showed higher intensities in protein-
speciﬁc Raman shifts (1300e1350 cm1, 1440 cm1, 1660 cm1)
when compared to skin-in-a-dishmodels. Additionally, the baseline
in Raman spectra from full-thickness skin-in-a-dish displayed some
ﬂuorescence background, which was not present in the Raman
spectra of disease-in-a-dish models (Fig. 5A). In order to generate a
model to classify unknown spectra, we employed PCA on the
spectral data sets. Seven PCs were calculated to describe the
spectral variances. The seven PCs explained a total variance of
97.4%. Based on the score values that were assigned for every single
Raman spectrum, a separation of full-thickness skin-in-a-dish and
disease-in-a-dish models was observed due to PC1, which accoun-
ted for 86% of the spectral variance. Raman spectra of skin-in-a-dish
models exhibited negative PC1 score values. In contrast, the spectra
of disease-in-a-dish models were assigned to positive score values
for PC1 (Fig. 5B). Interestingly, when Raman spectroscopy was
conducted on 2D-cultured primary keratinocytes and SCC-25 cells
in suspension, the spectra showed no signiﬁcant differences and
could thus not be used for a classiﬁcation model based on the PCA
(Suppl. Fig. 2). Therefore, we conclude that the spectral patterns of
both cell types are highly dependent on a physiological 3D
microenvironment as it is provided in native tissues. Raman spectra
of SCC-25 cells that were incorporated in full-thickness disease-in-
a-dish models reﬂected an altered morphology that was also
detected histologically.Fig. 5. Raman spectral analysis of full-thickness skin-in-a-dish and late-stage disease-in-a-
Differences in signal intensities are highlighted. Grey lines depict standard deviations. Sp
discrimination between full-thickness skin-in-a-dish and disease-in-a-dish models. PC 1 acc4. Discussion
In this study, SCC-25 cells were integrated into epidermal and
full-thickness skin equivalents. Early-stage epidermal disease-in-a-
dish models were generated by co-culturing keratinocytes and
SCC-25 cells. Hereby we observed that the differentiation and
stratiﬁcation of the epidermis is highly impacted by the number of
incorporated SCC-25 cells. Accordingly, increasing percentages of
SCC-25 cells resulted in a less organized epidermal structure with
insufﬁcient stratiﬁcation of the uppermost cell layer. Although no
formation of deﬁned tumor cell nests was detected in the
epidermal disease-in-a-dishmodels, the co-culture of keratinocytes
with SCC-25 cells allowed interaction and signaling between
healthy and malignant cells, as was previously described [14].
Insufﬁcient stratiﬁcation is a hallmark of precancerous lesions;
therefore, the here described epidermal disease-in-a-dish models
may enable the in-depth investigation of precancerous lesions such
as actinic keratosis and Bowen’s disease.
A major challenge for the detection of SCC is the lack of suitable
methods to visualize malignant cells in the epidermis. Various
marker proteins have been screened for the discrimination be-
tween keratinocytes and SCC-25 cells, but these cells share similar
protein expression patterns [11]. To overcome this problem, we
explored Raman spectroscopy as a non-invasive optical monitoring
technology. Raman spectroscopy was previously shown to be a
suitable tool for the label-free detection of molecular differences
between tumorigenic cells and primary cells in vitro [23]. Here,dish models. (A) Mean Raman spectra of skin-in-a-dish and disease-in-a-dish models.
ectra are shifted vertically for clarity. (B) Principal Component Analysis (PCA) allows
ounts for 87% of the total variance.
E. Brauchle et al. / Biomaterials 34 (2013) 7401e74077406different molecular patterns of keratinocytes and SCC-25 cells were
revealed by Raman spectra collected of full-thickness skin-in-a-dish
and late-stage disease-in-a-dish models. Both models exhibited a
speciﬁc spectral pattern, consisting of molecular signals from pro-
teins, nucleic acids and lipids [30]. Signiﬁcant differences in the
Raman spectra between the two models were detected by
employing PCA on the spectra. Protein-related signals at the Raman
shifts 1300e1350 cm1, 1440 cm1 and 1660 cm1 displayed higher
intensities in disease-in-a-dish models. Previously, increased pro-
tein signals in Raman spectrawere related to higher proliferation of
tumor cells when compared to healthy cells [31,32]. In our study, no
differences between the two cell types were detectable in 2D cell
cultures. Consequently, we hypothesize that the differential peak
intensities, seen in full-thickness skin-in-a-dish and disease-in-a-
dish models, were not only related to cell proliferation, but to dif-
ferences in the expression or the folding of epidermal-speciﬁc
keratins. In this context, we demonstrated that high amounts of
cytokeratin 5/6 and 14 were expressed in the accumulations
formed within the full-thickness disease-in-a-dish models. Inter-
estingly, the identiﬁed Raman signals were previously assigned to
keratin signals in skin [33], which strengthens our hypothesis.
Additionally, the Raman band at 1660 cm1, which is also known as
the amide I peak, was associated with malignant protein confor-
mations in other tissues [34]. Spectral regions around 1420 cm1
and 1640 cm1 were outlined in an in vivo study where Raman
spectroscopy was used to classify different skin cancer types
including SCC [35]. It was also shown that Raman spectra of the
epidermis differed in their signal intensities dependent on the
functionality and the thickness at the measured skin region [36].
According to the ﬁndings known from Raman spectroscopy on
healthy skin and SCC in vivo, we hypothesize that the molecular
changes that cause the discussed spectral differences are speciﬁc
for SCC. Molecular abnormalities detected in disease-in-a-dish
models together with histological staining indicate that the here
presented SCC in vitromodels correlate with SCC in vivo. PCA, which
was employed to compare these Raman spectra with those of skin-
in-a-dish models, showed signiﬁcant spectral shifts. Potential
classiﬁcation of in vitro skin models based on the PCA results was
indicated due to differential PC1 score values for standard skin-in-
a-dish and disease-in-a-dish models. In a previous report, similar
PCA-based classiﬁcations were generated for the visualization of
cells within porcine epidermis [37]. Notably, this is the ﬁrst
study reporting on Raman measurements for the comparison of
keratinocytes and SCC-25 cells within tissue-engineered skin
equivalents.
In standard full-thickness skin equivalents, keratinocytes
beneﬁt from soluble factors released by ﬁbroblasts that support
generation of a stratiﬁed and regular epidermis [28,29]. In this
study, full-thickness skin equivalents were generated with an
epidermis built from SCC-25 cells and a dermis composed either of
ﬁbroblasts alone, or co-cultured ﬁbroblasts and SCC-25 cells. In
contrast to other studies [11,12] where a different SCC cell line was
incorporated into 3D skin equivalents, we did not observe spon-
taneous invasion of SCC-25 cells into the dermal layer. However,
the epidermis containing SCC-25 cells displayed morphological
similarities to SCC in vivo, such as the presence of keratin pearls.
Additionally, small gaps in-between the epidermal SCC-25 cells
indicated weak cellecell contacts, which were conﬁrmed by
discontinuous immunohistochemical staining for E-cadherin. It
was previously shown that the expression of proteins related to
cellecell contacts, such as occludin, is down-regulated in squa-
mous cell carcinoma [38]. In our study, SCC-25 cells in the dermis
formed capsular tumor cell nests, containing cells at various stages
of differentiation, resembling SCC in vivo. Our observations indi-
cate that this behavior of SCC-25 cells is highly dependent onsoluble factors released by ﬁbroblasts, which play a pivotal role for
signaling that can lead to tumor progression in squamous head and
neck cancers [39].
5. Conclusions
In this study, SCC-25 cells were successfully integrated into
epidermal and full-thickness 3D skin equivalents to mimic an SSC
phenotype in vitro. Raman spectroscopy of full-thickness skin-in-a-
dish and disease-in-a-dish models displayed differential molecular
patterns for both models. Moreover, our results implicate an
important role of ﬁbroblasts for SCC progression and tumor cell
behavior. The presented epidermal and full-thickness disease-in-a-
dish models containing SCC-25 cells in the epidermis may enable
in-depth investigations on precancerous lesions in vitro. However,
in order to study invasive SCC, inﬁltration into the dermis had to be
simulated. Therefore, SCC-25 cells were seeded together with ﬁ-
broblasts directly into the dermal layer. Previously reported skin
equivalents generatedwith SCC cells exhibited onlyminor invasion,
without the presence of tumor cell nests, as observed in our ex-
periments. Altogether, the here presented SSC disease-in-a-dish
approaches offer the unique opportunity to model SSC in vitro,
which will allow further insight in SSC disease progression, and
facilitate the development of therapeutic strategies.
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